Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 4/2007

01-04-2007

Impact of Solitary Involved Lymph Node on Outcome in Localized Cancer of the Esophagus and Esophagogastric Junction

Authors: James M. O’Riordan, Suzanne Rowley, James O. Murphy, Narayasami Ravi, Patrick J. Byrne, John V. Reynolds

Published in: Journal of Gastrointestinal Surgery | Issue 4/2007

Login to get access

Abstract

Node-positive esophageal cancer is associated with a dismal prognosis. The impact of a solitary involved node, however, is unclear, and this study examined the implications of a solitary node compared with greater nodal involvement and node-negative disease. The clinical and pathologic details of 604 patients were entered prospectively into a database from1993 and 2005. Four pathologic groups were analyzed: node-negative, one lymph node positive, two or three lymph nodes positive, and greater than three lymph nodes positive. Three hundred and fifteen patients (52%) were node-positive and 289 were node-negative. The median survival was 26 months in the node-negative group. Patients (n = 84) who had one node positive had a median survival of 16 months (p = 0.03 vs node-negative). Eighty-four patients who had two or three nodes positive had a median survival of 11 months compared with a median survival of 8 months in the 146 patients who had greater than three nodes positive (p = 0.01). The survival of patients with one node positive [number of nodes (N) = 1] was also significantly greater than the survival of patients with 2–3 nodes positive (N = 2–3) (p = 0.049) and greater than three nodes positive (p < 0001). The presence of a solitary involved lymph node has a negative impact on survival compared with node-negative disease, but it is associated with significantly improved overall survival compared with all other nodal groups.
Literature
1.
go back to reference Roder JD, Busch R, Stein HJ, et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the esophagus. Br J Surg. 1994;81:410–413.PubMedCrossRef Roder JD, Busch R, Stein HJ, et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the esophagus. Br J Surg. 1994;81:410–413.PubMedCrossRef
2.
go back to reference HulscherJB, Van Sandick JW, De Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662–1669.PubMedCrossRef HulscherJB, Van Sandick JW, De Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662–1669.PubMedCrossRef
3.
go back to reference Ito H, Clancy TE, Osteen RT, et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199: 880–886.PubMedCrossRef Ito H, Clancy TE, Osteen RT, et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199: 880–886.PubMedCrossRef
4.
go back to reference Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 2001;234:581–587.PubMedCrossRef Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 2001;234:581–587.PubMedCrossRef
5.
go back to reference Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520–531.PubMedCrossRef Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520–531.PubMedCrossRef
6.
go back to reference Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–651.PubMedCrossRef Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–651.PubMedCrossRef
7.
go back to reference Lamb PJ, Griffin SM, Burt AD, et al. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg. 2005;92:60–67.PubMedCrossRef Lamb PJ, Griffin SM, Burt AD, et al. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg. 2005;92:60–67.PubMedCrossRef
8.
go back to reference Burian M, Stein HJ, Sendler A, et al. Sentinel node detection in Barrett’s and cardia cancer. Ann Surg Oncol. 2004;11:255S–258S.PubMed Burian M, Stein HJ, Sendler A, et al. Sentinel node detection in Barrett’s and cardia cancer. Ann Surg Oncol. 2004;11:255S–258S.PubMed
9.
go back to reference Luketich JD, Alvero-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: Outcomes in 222 patients. Ann Surg. 2003;238:486–494.PubMed Luketich JD, Alvero-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: Outcomes in 222 patients. Ann Surg. 2003;238:486–494.PubMed
10.
go back to reference Walsh TN, Noonan N, Hollywood D, Kelly A, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–467.PubMedCrossRef Walsh TN, Noonan N, Hollywood D, Kelly A, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–467.PubMedCrossRef
11.
go back to reference Digestive system: The esophagus. In: AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott, Williams and Wilkins, 1997, pp. 65–67. Digestive system: The esophagus. In: AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott, Williams and Wilkins, 1997, pp. 65–67.
12.
go back to reference Cox D. Regression models and life tables. J R Stat Soc. 1972;34:197–219. Cox D. Regression models and life tables. J R Stat Soc. 1972;34:197–219.
13.
go back to reference Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical/topographical classification in 1,002 consecutive patients. Ann Surg. 2000;232:353–361.CrossRef Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical/topographical classification in 1,002 consecutive patients. Ann Surg. 2000;232:353–361.CrossRef
14.
go back to reference Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88:921–932.PubMedCrossRef Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88:921–932.PubMedCrossRef
15.
go back to reference Dresner SM, Wayman J, Shenfine J, et al. Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg. 2000;87:362–373.CrossRef Dresner SM, Wayman J, Shenfine J, et al. Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg. 2000;87:362–373.CrossRef
16.
go back to reference Akiyama H, Tsurumara M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–372.PubMedCrossRef Akiyama H, Tsurumara M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–372.PubMedCrossRef
17.
go back to reference Eloubeidi MA, Desmond R. Prognostic factors for the survival of patients with esophageal cancer in the US. Cancer. 2002;95:1434–1443.PubMedCrossRef Eloubeidi MA, Desmond R. Prognostic factors for the survival of patients with esophageal cancer in the US. Cancer. 2002;95:1434–1443.PubMedCrossRef
18.
go back to reference Hsu CP, Chen CY, Hsia JY, Shai SE. Prediction of prognosis by the extent of lymph node involvement in squamus cell carcinoma of the thoracic esophagus. Eur J Cardio-thorac Surg. 2001;19:10–13.CrossRef Hsu CP, Chen CY, Hsia JY, Shai SE. Prediction of prognosis by the extent of lymph node involvement in squamus cell carcinoma of the thoracic esophagus. Eur J Cardio-thorac Surg. 2001;19:10–13.CrossRef
19.
go back to reference Gu Y, Swisher SG, Ajani JA, Correa AM. et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer. 2006;106:1017–1025.PubMedCrossRef Gu Y, Swisher SG, Ajani JA, Correa AM. et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer. 2006;106:1017–1025.PubMedCrossRef
Metadata
Title
Impact of Solitary Involved Lymph Node on Outcome in Localized Cancer of the Esophagus and Esophagogastric Junction
Authors
James M. O’Riordan
Suzanne Rowley
James O. Murphy
Narayasami Ravi
Patrick J. Byrne
John V. Reynolds
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 4/2007
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-006-0027-5

Other articles of this Issue 4/2007

Journal of Gastrointestinal Surgery 4/2007 Go to the issue